October 01, 2024 06:38 GMT
Bristol Myers Squibb (BMY: A2 neg / A): Lawsuit Dismissal
HEALTHCARE
- Small positive: BMY won a dismissal in a $6.4bn lawsuit alleging it delayed FDA approval to avoid paying milestones to Celgene shareholders
- Many had expected this to be settled pre-trial for an amount less than $6.4bn
35 words